PHIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phio Pharmaceuticals Corp (PHIO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no clear technical or proprietary trading signals suggest that this stock does not currently present a compelling investment opportunity.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 59.625, and moving averages are converging, suggesting no strong trend. The stock is trading near its resistance levels in pre-market at $1.34, which is above R1 ($1.32) but below R2 ($1.372).
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The stock has a 60% chance of declining by -2.82% in the next week and -3.89% in the next month based on historical candlestick patterns. Financial performance remains weak, with negative EPS and no revenue growth.
In Q4 2025, revenue remained at $0 with no growth. Net income improved by 45.82% YoY but remains negative at -$2,371,000. EPS dropped significantly by -82.52% YoY to -0.25, indicating worsening profitability.
No analyst ratings or price target changes available for this stock.
